<\/p>\n
<\/iframe><\/p>\n<p>Non-invasive, early detection of invasive cancers \u2014 dr. patrizia paterlini-brechot, founder, rarecells diagnostics, ISET technology.<\/p>\n<hr>\n<p>Dr. Patrizia Paterlini-Br\u00e9chot is a tenured Professor of Cell and Molecular Biology and Oncology at Paris Descartes University and head of a research team at the French National Institute of Health and Medical Research (INSERM).<\/p>\n<p>Dr. Paterlini-Br\u00e9chot studied medicine at the University of Modena and Reggio Emilia, where she specialized in hematology and oncology. In 1988 she turned her focus on research in cell and molecular biology and published over 80 research articles and reviews in national and international scientific journals.<\/p>\n<p>The work of Dr. Paterlini-Br\u00e9chot led to the discovery of the ISET test (Isolation by SizE of Tumor cells) permitting the isolation and characterization of circulating tumor cells (CTCs), a type of cell that has shed into the vasculature from a primary tumor, is carried around the body in the blood circulation, and can extravasate and become seeds for the subsequent growth of additional tumors (metastases) in distant organs, a mechanism that is responsible for the vast majority of cancer-related deaths.<\/p>\n<p>The ISET test also has interesting applications for the isolation of fetal cells in a mother\u2019s body for potential use in prenatal diagnoses.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2021\/02\/dr-patrizia-paterlini-brechot-founder-rarecells-non-invasive-early-detection-of-invasive-cancer\">Continue reading \u201cDr Patrizia Paterlini-Br\u00e9chot, Founder, Rarecells \u2014 Non-Invasive, Early Detection Of Invasive Cancer\u201d | ><\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Non-invasive, early detection of invasive cancers \u2014 dr. patrizia paterlini-brechot, founder, rarecells diagnostics, ISET technology. Dr. Patrizia Paterlini-Br\u00e9chot is a tenured Professor of Cell and Molecular Biology and Oncology at Paris Descartes University and head of a research team at the French National Institute of Health and Medical Research (INSERM). Dr. Paterlini-Br\u00e9chot studied medicine at [\u2026]<\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-119648","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/119648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=119648"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/119648\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=119648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=119648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=119648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}